<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="abstract" dtd-version="1.0" xml:lang="en" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CC</journal-id>
<journal-id journal-id-type="nlm-ta">Cardiol Croat</journal-id>
<journal-title-group>
<journal-title>Cardiologia Croatica</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Cardiol. Croat.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">1848-543X</issn>
<issn pub-type="epub">1848-5448</issn>
<publisher><publisher-name>Croatian Cardiac Society</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">CC 2025 20_1-2_27</article-id>
<article-id pub-id-type="doi">10.15836/ccar2025.27</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Extended Abstract</subject></subj-group>
<subj-group subj-group-type="subheading"><subject>Structural Heart Disease Interventions</subject></subj-group>
</article-categories>
<title-group>
<article-title>Residual shunt after patent foramen ovale closure &#x2013; a retrospective analysis of outcomes at University Hospital Centre Zagreb</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4004-7271</contrib-id><name><surname>Mari&#x0107; Be&#x0161;i&#x0107;</surname><given-names>Kristina</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1">*</xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3490-5505</contrib-id><name><surname>Do&#x0161;en</surname><given-names>Denis</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4721-3236</contrib-id><name><surname>Re&#x0161;kovi&#x0107; Luk&#x0161;i&#x0107;</surname><given-names>Vlatka</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7349-6137</contrib-id><name><surname>Jak&#x0161;i&#x0107; Jurinjak</surname><given-names>Sandra</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6910-9720</contrib-id><name><surname>Ivanac Vrane&#x0161;i&#x0107;</surname><given-names>Irena</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6276-4450</contrib-id><name><surname>Kova&#x010D;</surname><given-names>Antun Zvonimir</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1482-6503</contrib-id><name><surname>Bulum</surname><given-names>Jo&#x0161;ko</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<aff id="aff1"><label>1</label><institution>University Hospital Centre Zagreb</institution>, <addr-line>Zagreb</addr-line>, <country country="hr">Croatia</country></aff>
<aff id="aff2"><label>2</label><institution>University of Zagreb School of Medicine</institution>, <addr-line>Zagreb</addr-line>, <country country="hr">Croatia</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>ADDRESS FOR CORRESPONDENCE: Kristina Mari&#x0107; Be&#x0161;i&#x0107;, Klini&#x010D;ki bolni&#x010D;ki centar Zagreb, Ki&#x0161;pati&#x0107;eva 12, HR-10000 Zagreb, Croatia. / Phone: +385-91-2336-805 / E-mail: <email xlink:href="kmaricbesic@gmail.com">kmaricbesic@gmail.com</email></corresp></author-notes>
<pub-date date-type="pub" publication-format="electronic"><month>03</month><year>2025</year></pub-date>
<pub-date date-type="pub" publication-format="print"><month>03</month><year>2025</year></pub-date>
<volume>20</volume>
<issue>1-2</issue>
<fpage>27</fpage>
<lpage>27</lpage>
<history>
<date date-type="received"><day>04</day><month>02</month><year>2025</year></date>
<date><day>14</day><month>02</month><year>2025</year></date>
</history>
<permissions>
<copyright-statement>Croatian Cardiac Society</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Croatian Cardiac Society</copyright-holder>
</permissions>
<kwd-group kwd-group-type="author"><title>KEYWORDS: </title><kwd>patent foramen ovale</kwd><kwd>residual shunt</kwd><kwd>device size</kwd></kwd-group>
</article-meta>
</front>
<body>
<p><bold>Introduction</bold>: Patent foramen ovale (PFO) closure is a widely performed procedure with a success rate exceeding 98%. However, residual right-to-left interatrial shunting can persist in up to 30% of cases (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>, <xref ref-type="bibr" rid="r2"><italic>2</italic></xref>)<sup>.</sup> The occurrence and size of residual shunts are influenced by the anatomical characteristics of the PFO and the dimensions of the implanted closure device (<xref ref-type="bibr" rid="r3"><italic>3</italic></xref>). We aimed to evaluate the incidence of residual shunting, and its correlation with the size of the Amplatzer occluder device at the University Hospital Centre (UHC) Zagreb.</p>
<p><bold>Patients and Methods</bold>: A retrospective analysis was conducted on all patients who underwent PFO closure at the UHC Zagreb to date. The study assessed implantation success rates, device sizing, echocardiographic follow-up methods and frequency, and the detection of residual shunts. Statistical analysis was performed using the Chi-square test and Cramer&#x2019;s V test.</p>
<p><bold>Results</bold>: Between August 2016 and December 2024, a total of 104 PFO closures were attempted, with 100 (96.2%) successfully implanted. Various sizes of Amplatzer occluder devices were used: 65 patients (66%) received smaller devices: 18/25 mm or 25/25 mm, while 33 patients (34%) received larger ones: 25/30 mm, 25/35 mm or 30/30 mm. Size data was unavailable for 2 cases. During the first year of follow-up, residual shunts were assessed in 41 patients (39.4%) using TTE/transesophageal echocardiography (TEE) with color Doppler and in 59 patients (56.7%) using TTE with a bubble test. Residual shunting was detected in 18 patients (18.3%) exclusively with the TTE bubble test, 78% with larger devices. TTE with bubble test beyond one year was performed in 14 (out of 19) patients. A persistent residual shunt was found in 11 patients (10.6%), again in 73% patients with larger devices. A statistically significant difference was observed in the occurrence of residual shunting among different device sizes (Chi-square, p&lt;0.001), with a higher likelihood of residual shunting as device size increased (Cramer&#x2019;s V = 0.577, p&lt;0.001).</p>
<p><bold>Conclusion</bold>: PFO closure outcomes at our center align with data from literature. The findings confirm that larger closure devices are associated with a higher likelihood of residual shunting. TTE with bubble test is superior to Doppler-based methods in detecting residual shunting and therefore important for follow-up assessments.</p>
</body>
<back>
<ref-list>
<title>LITERATURE</title>
<ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>W</given-names></name><name><surname>Yin</surname><given-names>S</given-names></name><name><surname>McMullin</surname><given-names>D</given-names></name><name><surname>Inglessis-Azuaje</surname><given-names>I</given-names></name><name><surname>Elmariah</surname><given-names>S</given-names></name><name><surname>Hung</surname><given-names>J</given-names></name><etal/></person-group> <article-title>Residual Shunt After Patent Foramen Ovale Closure and Long-Term Stroke Recurrence: A Prospective Cohort Study.</article-title> <source>Ann Intern Med</source>. <year>2020</year> June 2;<volume>172</volume>(<issue>11</issue>):<fpage>717</fpage>&#x2013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.7326/M19-3583</pub-id><pub-id pub-id-type="pmid">32422058</pub-id></mixed-citation></ref>
<ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>S&#x00F8;ndergaard</surname><given-names>L</given-names></name><name><surname>Kasner</surname><given-names>SE</given-names></name><name><surname>Rhodes</surname><given-names>JF</given-names></name><name><surname>Andersen</surname><given-names>G</given-names></name><name><surname>Iversen</surname><given-names>HK</given-names></name><name><surname>Nielsen-Kudsk</surname><given-names>JE</given-names></name><etal/><collab>Gore REDUCE Clinical Study Investigators</collab></person-group>. <article-title>Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke.</article-title> <source>N Engl J Med</source>. <year>2017</year> September 14;<volume>377</volume>(<issue>11</issue>):<fpage>1033</fpage>&#x2013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1707404</pub-id><pub-id pub-id-type="pmid">28902580</pub-id></mixed-citation></ref>
<ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marchese</surname><given-names>N</given-names></name><name><surname>Pacilli</surname><given-names>MA</given-names></name><name><surname>Inchingolo</surname><given-names>V</given-names></name><name><surname>Fanelli</surname><given-names>R</given-names></name><name><surname>Loperfido</surname><given-names>F</given-names></name><name><surname>Vigna</surname><given-names>C</given-names></name></person-group>. <article-title>Residual shunt after percutaneous closure of patent foramen ovale with AMPLATZER occluder devices - influence of anatomic features: a transcranial Doppler and intracardiac echocardiography study.</article-title> <source>EuroIntervention</source>. <year>2013</year> July;<volume>9</volume>(<issue>3</issue>):<fpage>382</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.4244/EIJV9I3A61</pub-id><pub-id pub-id-type="pmid">23872652</pub-id></mixed-citation></ref>
</ref-list>
</back>
</article>
